Position in GILD
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$460,256
-$47,608 QoQ
Shares Held
3,643
-0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,410
of 2,266 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Avantax Planning Partners, Inc. holds $68,697,880 across 9 Drug Manufacturers - General names. GILD ranks #8 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
61,376 | $15,444,656 | |
| 2 | MRK |
Merck & Co., Inc.
|
100,354 | $12,895,489 | |
| 3 | JNJ |
Johnson & Johnson
|
45,393 | $11,528,460 | |
| 4 | AMGN |
Amgen Inc
|
28,579 | $10,349,027 | |
| 5 | LLY |
ELI LILLY & Co
|
6,678 | $8,009,794 | |
| 6 | PFE |
Pfizer Inc
|
237,765 | $5,725,381 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
67,492 | $3,888,889 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,643 | $460,256 |
All Filings in GILD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $460,256 | 3,643 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $507,864 | 3,644 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $445,791 | 3,632 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $366,633 | 3,303 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $407,558 | 3,676 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $414,921 | 3,703 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $337,981 | 3,659 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $279,774 | 3,337 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $252,141 | 3,675 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $272,783 | 3,724 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $354,985 | 4,382 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $337,230 | 4,500 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $297,181 | 3,856 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $318,770 | 3,842 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $341,597 | 3,979 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $228,623 | 3,706 | Shares | Sole | 2022-10-14 | |
| 2022-03-31 | $201,832 | 3,395 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $205,413 | 2,829 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $230,505 | 3,300 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $227,238 | 3,300 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $253,414 | 3,921 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $277,026 | 4,755 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $370,167 | 5,858 | Shares | Sole | 2020-10-28 | |
| 2020-06-30 | $380,314 | 4,943 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $331,261 | 4,431 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||